CUBE vs TVTX · P/E 25, rev $1.07B vs rev $233.2M
CubeSmart (CUBE) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TVTX revenue for 2024-12-31 was $233.2M. Net income was -$321.5M. Revenue was up 417.5% from 2023-12-31 to 2024-12-31. TVTX currently screens at market cap $1.33B.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the CUBE and TVTX stock pages for the full models.
Not investment advice.